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“You can’t manage what you don’t measure.”
The world community–led by the IMACS and PRINTO
groups–has developed robust core criteria to measure dis-
ease activity and damage for Juvenile Dermatomyositis
studies. These measures are tremendously useful in clini-
cal practice, and not just for research.
More problematic has been determining clinically mean-
ingful change. The current definitions of change may not
be adequate for clinical trials. Problems include mathema-
tical theoretical ones (e.g. using percent [relative] change
for non-ratio measures, and trying to calculate continuous
scores from ordinal measures), and practical ones (not
incorporating patients’ subjective assessments properly).
Proper measures have an important place in the clinical
care of children with dermatomyositis; we have made a
very strong start, but there is still work to do.
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